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Gold nanoparticles were obtained using a green synthesis approach with aqueous earthworm extracts without any
additional reducing or capping agents. The gold nanoparticles were characterized using UV-visible spectrophotometry,
high-resolution transmission electron microscopy, atomic force microscopy, field emission scanning electron microscopy,
X-ray diffraction, Fourier transform infrared spectroscopy, and inductively coupled plasma mass spectrometry. The
anticoagulant activity of the gold nanoparticles was assessed using the activated partial thromboplastin time and
was mildly enhanced by combining the gold nanoparticles with heparin. In addition to the generation of spherical
nanoparticles with an average diameter of 6.13 ± 2.13 nm, cubic and block-shaped nanoparticles with an average aspect
ratio, defined as the length divided by width, of 1.47 were also observed.
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Recent advances in nanotechnology have enabled the
exploration of nanomaterials for diverse applications.
Among the variety of nanomaterials, gold nanoparticles
(AuNPs) are of considerable interest due to their versa-
tility and potential uses in chemistry, biology, medicine,
and pharmaceuticals. AuNPs possess numerous advan-
tages, such as low cytotoxicity, facile modification of their
surfaces, straightforward synthetic processes, and excellent
biocompatibility [1,2]. Currently, research interest in gold
nanomedicine is rapidly expanding. In 2010, approximately
14% of all publications on nanomedicine were directly
related to gold nanomedicine [3].
The common approach for synthesizing AuNPs employs
sodium citrate and/or sodium borohydride as reducing
agents to convert gold salts into AuNPs. The emergence of
sustainability initiatives has increased the use of biological* Correspondence: youmiep@inje.ac.kr
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in any medium, provided the original work is pentities as reducing agents in AuNP synthesis (i.e., green
synthesis) to replace toxic chemicals. Many authors have
extensively reported the green synthesis of AuNPs using
diverse biological entities. These green synthetic processes
are rapid, eco-friendly, and cost-effective, and they can eas-
ily be scaled up [4-8]. Examples of these diverse biological
entities include plant extracts, polysaccharides, bacteria,
fungi, yeasts, DNA, RNA, proteins, and polypeptides. We
used aqueous earthworm (Eisenia andrei) extracts as a
reducing agent for the green synthesis of AuNPs
(EW-AuNPs). Earthworm extracts reportedly have anti-
coagulant, fibrinolytic, and antithrombotic activities [9-14].
Trisina and co-workers reported that the protein extracts
from Lumbricus rubellus are responsible for antithrom-
botic and thrombolytic activities [14]. In addition to pro-
teins, glycosaminoglycans (chondroitin/dermatan sulfates
and heparan sulfate) are also present in earthworm
(E. andrei) extracts [15].
EW-AuNPs were characterized using UV-visible spec-
trophotometry, high-resolution transmission electron
microscopy (HR-TEM), atomic force microscopy (AFM),
field emission scanning electron microscopy (FE-SEM),
X-ray diffraction (XRD), Fourier transform infrared spec-
troscopy (FT-IR), and inductively coupled plasma massOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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Figure 1 UV-visible spectra, XRD analysis, and FT-IR spectra of
EW-AuNPs. (A) UV-visible spectra before and after the oven incubation.
The inset depicts the color change of the AuNP solution. (B) XRD
analysis of the EW-AuNPs. (C) FT-IR spectra of the EW and EW-AuNPs.
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coagulant activity is reportedly among the major biological
activities of earthworm extracts; therefore, we assessed the
anticoagulant activities of EW-AuNPs both alone and in
combination with heparin.
Methods
Hydrochloroauric acid trihydrate (HAuCl4 · 3H2O) and
Minisart® syringe filters (0.45 μm; Sartorius AG, Goettingen,
Germany) were obtained from Sigma-Aldrich (St. Louis,
MO, USA). Earthworm (E. andrei) powders were obtained
from a local supplier (Hwasun, Cheollanam-Do, Republic
of Korea). Heparin sodium injection was obtained from JW
Pharmaceutical (Seoul, Republic of Korea). All other re-
agents were of analytical grade. We previously reported
the green synthesis of AuNPs using aqueous earthworm
(E. andrei) extracts, the reaction process was optimized,
and HR-TEM images of the AuNPs were obtained [16].
This procedure, with a minor modification, was utilized
in this study. The earthworm powder (150 mg) was dis-
persed in deionized water (50 mL) and sonicated for
30 min. The insoluble pellet was removed after centrifuga-
tion at 5,067 × g for 10 min (Eppendorf 5424R centrifuge,
Eppendorf AG, Hamburg, Germany). The supernatant
was subsequently filtered through filter paper and a
Minisart® filter (0.45 μm) and then freeze-dried. The
freeze-dried material was used to synthesize the EW-
AuNPs according to the following procedures: the earth-
worm extract (500 μL, 0.3% in deionized water) was
mixed with HAuCl4 · 3H2O (500 μL, 0.6 mM in deionized
water), and the mixture was incubated in an 80°C oven
for 11 h. The reaction yield was measured by detect-
ing the concentration of unreacted Au3+ via ICP-MS,
which was conducted using an ELAN 6100 instrument
(PerkinElmer SCIEX, Waltham, MA, USA). The samples
containing unreacted Au3+ were prepared either by ultra-
centrifugation or by filtration. Ultracentrifugation was per-
formed in an Eppendorf 5424R centrifuge at 21,130 × g for
1 h at 18°C. Under this ultracentrifugation condition,
AuNPs remained as a wine-red pellet, and the color of the
supernatant turned colorless. The supernatant containing
the unreacted Au3+ was then pooled and analyzed via ICP-
MS. The EW-AuNP solution was filtered through a syringe
equipped with a Minisart® filter (0.45 μm). The colorless
filtrate was also analyzed via ICP-MS. ICP-MS analysis
was performed in triplicate to obtain an average yield. A
Shimadzu UV-1800 spectrophotometer was used to ac-
quire the UV-visible spectra (Shimadzu Corporation,
Kyoto, Japan). A JEOL JEM-3010 TEM (JEOL Ltd., Tokyo,
Japan) operating at 300 kV with samples on a carbon-
coated copper grid (carbon type-B, 300 mesh, Ted Pella
Inc., Redding, CA, USA) was used to obtain the HR-TEM.
The AFM images were acquired using a Dimension® Icon®
(Bruker Nano, Inc., Santa Barbara, CA, USA) with anRTESP probe (MPP-11100-10, premium high-resolution
tapping-mode silicon probe, Bruker Nano, Inc., Santa
Barbara, CA, USA) in tapping mode. The mica (grade V-
1, 25 mm× 25 mm, 0.15-mm thick) was acquired from
the SPI Supplies Division of Structure Probe, Inc. (West
Chester, PA, USA) and was used for the sample depos-
ition. FE-SEM images were obtained using a JSM-7100 F
with an accelerating voltage of 15 kV (JEOL Ltd., Tokyo,
Japan). The samples were lyophilized with a FD5505
(A)  (B) (C)  (D) (E)  (F)
Figure 3 Anticoagulant activity according to the aPTT assay.
The values in parentheses indicate the final concentrations of each
component in the assay. (A) Negative control (deionized water),
(B) positive control (heparin, 0.02 U/mL), (C) the extract (0.03%),
(D) the EW-AuNPs (0.03% EW and 60 μM HAuCl4 · 3H2O), (E) a
combination of heparin (0.02 U/mL) with sample (C), and (F) a
combination of heparin (0.02 U/mL) with sample (D).
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FT-IR spectra were acquired with a KBr pellet of the
freeze-dried samples using a Nicolet 6700 spectrometer
(Thermo Fisher Scientific, Waltham, MA, USA) over a
range of 400 ~ 4,000 cm−1. XRD analysis was performed
using a Bruker D8 Discover high-resolution X-ray diffract-
ometer (Bruker, Karlsruhe, Germany) with CuKα radiation
(λ = 0.154056 nm) over the range of 20° ~ 90° (2θ scale). A
tenfold AuNP concentrate was processed under an N2 at-
mosphere to assess the activated partial thromboplastin
time (aPTT) using a procedure adapted from our previous
report [17].
Results and discussion
Green synthesis and yield of EW-AuNPs
As depicted in Figure 1A, the wine-red color of the EW-
AuNPs after incubation in an oven confirmed the success-
ful synthesis of the AuNPs. The surface plasmon resonance
band of AuNPs was observed at 533 nm. ICP-MS is an(A) (B)
(C) (D)
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Figure 2 HR-TEM images of the EW-AuNPs. The scale bar represents (A) 50 nm, (B) 5 nm, and (C) 5 nm. (D) Size histogram.
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Figure 4 AFM images of the EW-AuNPs. (A) 3-D height image (500 nm × 500 nm), (B) 2-D height image (2.5 μm× 2.5 μm), (C) 2-D amplitude
error image (2.5 μm× 2.5 μm), (D) 3-D amplitude error image (2.5 μm× 2.5 μm), (E) 3-D height image (2.5 μm× 2.5 μm), and (F) cross-sectional
analysis of both the length (line a-b) and the width (line c-d) from B.
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unreacted Au3+ at the ppt level. The concentration of the
EW-AuNPs solution was measured by ICP-MS as 95,192.2
parts per billion (ppb) which was the initial Au3+ concen-
tration used for the synthesis. The concentrations of
the unreacted Au3+ were measured by ICP-MS as
8,455.6 and 7,151.1 ppb with the ultracentrifugation and
filtration methods, respectively. Thus, the ultracentrifu-
gation method obtained a yield of 91.1%, and the filtra-
tion method obtained a yield of 92.5%. The characteristic
wine-red color of the EW-AuNPs disappeared after ultra-
centrifugation or filtration, indicating that the AuNPs
were successfully separated from the unreacted Au3+.
XRD analysis
The crystalline nature of the EW-AuNPs was determined
via XRD analysis, as shown in Figure 1B. The diffraction
peaks at 38.3°, 44.7°, 64.7°, and 77.4° corresponded to the
(111), (200), (220), and (311) planes of crystalline Au, re-
spectively, indicating a face-centered cubic structure.
FT-IR spectra
As shown in Figure 1C, in the earthworm sample, the
O-H stretching vibration appeared at 3,414 cm−1 as an(A)
(C)
10 µm
1 µm
Figure 5 FE-SEM images of the EW-AuNPs. The scale bar represents (A)intense and broad band. The two bands at 2,919 and
2,850 cm−1 were identified as the methylene vibrations
of the hydrocarbons from the proteins/peptides [18].
The carbonyl (C =O) stretching vibration at 1,658 cm−1
from the amide functional groups also indicated the pres-
ence of proteins/peptides [18,19]. The band at 1,587 cm−1
resulted from the N-H bending vibration of the amide
functional groups. The COO– stretching vibration ap-
peared at 1,412 cm−1. The bands from the earthworm
sample suggested that proteins/peptides were the major
compounds present in the sample. After synthesis of the
EW-AuNPs, these bands shifted from 3,414 to 3,440 cm−1,
from 2,919 to 2,914 cm−1, from 2,850 to 2,854 cm−1, from
1,658 to 1,637 cm−1, and from 1,412 to 1,406 cm−1. Based
on these shifts, the proteins/peptides in the extract are
likely responsible for the reduction of Au3+ to generate
the AuNPs.
HR-TEM images and size histogram
The EW-AuNPs were primarily spherical with an aver-
age diameter of 6.13 ± 2.13 nm (Figure 2). A collection
of 105 discrete AuNPs were randomly selected from the
HR-TEM images to measure the average diameter. The
two most abundant diameters were 4 ~ 5 and 7 ~ 8 nm,(B)
(D)
100 nm
1 µm
10 μm, (B) 1 μm, (C) 1 μm, and (D) 100 nm.
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lattice fringes further confirmed the crystalline structure
of the EW-AuNPs (Figure 2B,C). We previously ob-
tained spherical EW-AuNPs with the diameter of 6.70 ±
2.69 nm using a green synthesis route with different
reaction conditions [16].
Anticoagulant activity via aPTT assay
The EW-AuNPs reinforced or enhanced the anticoagu-
lant activity of heparin by aPTT assay when the combin-
ation of EW-AuNPs and heparin was used for treatment
(Figure 3). The clotting times of the negative (deionized
water) and positive (heparin) controls were 44.1 and
50.8 s, respectively (Figure 3 parts A and B). No signifi-
cant anticoagulant activities were noted in the extract
(47.2 s, Figure 3 part C), the EW-AuNPs (44.8 s, Figure 3
part D), or in heparin combined with the extract (50.9 s,
Figure 3 part E). However, when heparin and the EW-
AuNPs were combined, the clotting time was extended
to 60.4 s (Figure 3 part F), which corresponds to an in-
crease of 118.9% and 134.8% over the clotting times of
the same concentrations of the positive control (heparin)
and the EW-AuNPs, respectively.
AFM images
As depicted in Figure 4A, the obtained AuNPs were
primarily spherical. This result is consistent with the HR-
TEM images presented in Figure 2. Following an ultracen-
trifugation/resuspension process, the pellets (EW-AuNPs)
were redispersed in deionized water and examined via
AFM. The 2-D and 3-D images demonstrated that cubic
and block-shaped AuNPs were also present as minor com-
ponents (Figure 4B,C,D,E). Cross-sectional analysis further
confirmed the block shape of the AuNPs (Figure 4F).
FE-SEM images
When we imaged the cubic and block-shaped AuNPs via
FE-SEM, these shapes appeared in a line that resembled
fish bones (Figure 5A). A more detailed examination re-
vealed cubic and block-shaped anisotropic particles. The
width varied from 0.11 to 0.33 μm, and the length varied
from 0.13 to 0.93 μm (Figure 5B). The aspect ratio is de-
fined as the length divided by the width. The average as-
pect ratio was 1.47, with values ranging between 1.0 and
2.8. The largest observed block had a width of 0.33 μm,
a length of 0.93 μm, and a maximum aspect ratio of 2.8
(Figure 5D). Murphy and co-workers reported that surfac-
tants such as cetyltrimethylammonium bromide or small
ions act as structure-directing agents in the formation of
anisotropic nanostructures [20]. We hypothesize that the
structure-directing agents in the extracts likely induced
the formation of anisotropic shapes during synthesis. We
previously reported the presence of glycosaminoglycans in
these earthworm extracts [15]. Glycosaminoglycans arewater-soluble compounds with large negative charges that
can act as structure-directing agents. Based on the inter-
pretation of the FT-IR spectra, proteins/peptides are the
likely other candidates.
Conclusions
We report the green synthesis of AuNPs using aqueous
earthworm extracts as reducing agents to convert Au3+
to AuNPs and the characterization of these AuNPs. The
reactions occurred in water without the use of any other
toxic chemicals; thus, the resulting AuNPs were available
for subsequent biological tests. Anisotropic NPs were
observed in addition to the spherical NPs. We are un-
able to explain how the anisotropic NPs were generated,
and this topic will be explored in future work. From the
FT-IR spectra, we could conclude that the proteins/
peptides in the extract were involved in the reduction
of Au3+ and in the stabilization of the EW-AuNPs. In
addition, the anticoagulant activity of heparin was rein-
forced when combined with the EW-AuNPs, which
suggests that AuNPs are involved in the blood coagulation
cascade. The current study demonstrates that the newly
prepared AuNPs are promising candidates for novel gold
nanomedicines.
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